Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| T47D | Alvocidib | 1.0 | -0.0994 | 0.04134 |
| T47D | Alvocidib | 1.0 | -0.1513 | 0.01246 |
| T47D | Alvocidib | 1.0 | -0.1548 | 0.02098 |
| T47D | GSK2334470 | 0.001 | 0.9855 | -0.00173 |
| T47D | GSK2334470 | 0.001 | 0.9442 | -0.00399 |
| T47D | GSK2334470 | 0.001 | 0.8871 | -0.00120 |
| T47D | GSK2334470 | 0.003162278 | 0.9935 | -0.00249 |
| T47D | GSK2334470 | 0.003162278 | 0.7317 | 0.00297 |
| T47D | GSK2334470 | 0.003162278 | 0.7979 | 0.01127 |
| T47D | GSK2334470 | 0.01 | 0.7439 | 0.00861 |
| T47D | GSK2334470 | 0.01 | 0.8590 | -0.00487 |
| T47D | GSK2334470 | 0.01 | 0.8170 | 0.00755 |
| T47D | GSK2334470 | 0.031622777 | 0.7445 | -0.00673 |
| T47D | GSK2334470 | 0.031622777 | 0.6713 | -0.00512 |
| T47D | GSK2334470 | 0.031622777 | 0.6631 | 0.00044 |
| T47D | GSK2334470 | 0.1 | 0.6760 | 0.00065 |
| T47D | GSK2334470 | 0.1 | 0.7141 | 0.00127 |
| T47D | GSK2334470 | 0.1 | 0.6098 | 0.00001 |
| T47D | GSK2334470 | 0.316227766 | 0.5232 | 0.01295 |
| T47D | GSK2334470 | 0.316227766 | 0.5424 | 0.00159 |
| T47D | GSK2334470 | 0.316227766 | 0.4749 | 0.03002 |
| T47D | GSK2334470 | 1.0 | 0.4755 | 0.00668 |
| T47D | GSK2334470 | 1.0 | 0.4415 | 0.00748 |
| T47D | GSK2334470 | 1.0 | 0.3519 | 0.01030 |
| T47D | GSK2334470 | 3.16227766 | 0.2867 | 0.02053 |